The tweet was deleted by the author.
But we saved everything 🙂.
Brandon Beylo expresses skepticism about widespread claims that gold has reached its bottom.
He questions the ease with which some market observers are identifying a turning point for gold, noting that markets do not usually operate in such a straightforward manner. Beylo also indicates suspicion regarding the confidence of those calling the bottom at this stage.
Earlier this year, Beylo highlighted gold trading at $4,000 and questioned whether that level may be seen as a rare opportunity in the future (link). He has also commented on corporate activity, noting Vertex Pharma's acquisition of Crinetics Pharma at a 100 percent premium (link). Beylo’s previous commentary reflects ongoing attention to both commodity prices and corporate deals.